Selected
Type of publications
Regions
Countries
Diseases
Publication date
Target population
Available to download in languages
1292 results found
2023 ∙ Chen, S. Wei, W. Huang, F. Wang, J. Li, X. Gen, Z. Gao, F. Dong, T. Wei, P. Yang, X. Miao, F.
A systematic review and meta-analysis of the seroconversion rates and adverse effects of COVID-19 mRNA vaccine and COVID-19 viral vector vaccine in kidney transplant recipient patients
  • Vaccine/vaccination
  • Safety
  • Efficacy/effectiveness
  • All age groups
  • COVID-19
Rating:
Critically low
2023 ∙ Mohammed, H. Pham-Tran, D. D. Yeoh, Z. Y. M. Wang, B. McMillan, M. Andraweera, P. H. Marshall, H. S.
A Systematic Review and Meta-Analysis on the Real-World Effectiveness of COVID-19 Vaccines against Infection, Symptomatic and Severe COVID-19 Disease Caused by the Omicron Variant (B.1.1.529)
  • Vaccine/vaccination
  • Efficacy/effectiveness
  • All age groups
  • Healthcare workers
  • COVID-19
Rating:
Critically low
2023 ∙ Whitehead, H. S. French, C. E. Caldwell, D. M. Letley, L. Mounier-Jack, S.
A systematic review of communication interventions for countering vaccine misinformation
  • Vaccine/vaccination
  • Acceptance
  • All age groups
  • Parents/caregivers
  • COVID-19
Rating:
Not applicable
2023 ∙ Jagne, Isatou von Mollendorf, Claire Wee-Hee, Ashleigh Ortika, Belinda Satzke, Catherine Russell, Fiona M.
A systematic review of pneumococcal conjugate vaccine impact on pneumococcal nasopharyngeal colonisation density in children under 5 years of age
  • Efficacy/effectiveness
  • Newborn
  • Children
  • Pneumococcal disease
Rating:
Low
2023 ∙ Doggen, Kris van Hoek, Albert Jan Luyten, Jeroen
Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella
  • Economic aspects
  • Newborn
  • Children
  • Adolescents
  • Adults
  • Pneumococcal disease
  • Rotavirus
  • Human papillomavirus (HPV)
  • Meningococcal disease
  • Mumps
  • Measles
  • Rubella
Rating:
Not applicable
2023 ∙ Dadari, I. Belt, R. V. Iyengar, A. Ray, A. Hossain, I. Ali, D. Danielsson, N. Sodha, S. V.
Achieving the IA2030 Coverage and Equity Goals through a Renewed Focus on Urban Immunization
  • Coverage
  • Ethical issues
  • Newborn
  • Children
  • Adolescents
Rating:
Not applicable
2023 ∙ Pichichero, Michael Malley, Richard Kaur, Ravinder Zagursky, Robert Anderson, Porter
Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new pneumococcal conjugate vaccines
  • Efficacy/effectiveness
  • Children
  • Adolescents
  • Pneumococcal disease
Rating:
Critically low
2023 ∙ Yasmin, F. Najeeb, H. Naeem, U. Moeed, A. Atif, A. R. Asghar, M. S. Nimri, N. Saleem, M. Bandyopadhyay, D. Krittanawong, C. Fadelallah Eljack, M. M. Tahir, M. J. Waqar, F.
Adverse events following COVID-19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia
  • Vaccine/vaccination
  • Safety
  • All age groups
  • COVID-19
Rating:
Critically low
2023 ∙ Watanabe, A. Kani, R. Iwagami, M. Takagi, H. Yasuhara, J. Kuno, T.
Assessment of Efficacy and Safety of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years: A Systematic Review and Meta-analysis
  • Efficacy/effectiveness
  • Safety
  • Vaccine/vaccination
  • Children
  • Adolescents
  • COVID-19
Rating:
Critically low
2023 ∙ Bansal, D. Kamboj, M. Anand, R. Pandiar, D. Narwal, A. Sivakumar, N. Devi, A.
Association of childhood vaccination with pediatric lichen planus: A systematic review
  • Safety
  • Children
  • Adolescents
Rating:
Critically low